SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases

Fuqing Wu(Massachusetts Institute of Technology), Amy Xiao(Massachusetts Institute of Technology), Zhang Jb(Massachusetts Institute of Technology), XQ Gu(National University of Singapore), WL Lee(National University of Singapore), Kathryn M. Kauffman(University at Buffalo, State University of New York), WP Hanage(Center for Disease Dynamics, Economics & Policy), Marcelo Matus, Newsha Ghaeli, Noriko Endo, Claire Duvallet, Katya Moniz(Massachusetts Institute of Technology), TB Erickson(Brigham and Women's Hospital), PR Chai(Brigham and Women's Hospital), Joseph Thompson(Nanyang Technological University), EJ Alm(National University of Singapore)
medRxiv
April 7, 2020
Cited by 260Open Access
Full Text

Abstract

Abstract Wastewater surveillance may represent a complementary approach to measure the presence and even prevalence of infectious diseases when the capacity for clinical testing is limited. Moreover, aggregate, population-wide data can help inform modeling efforts. We tested wastewater collected at a major urban treatment facility in Massachusetts and found the presence of SARS-CoV-2 at high titers in the period from March 18 - 25 using RT-qPCR. We then confirmed the identity of the PCR product by direct DNA sequencing. Viral titers observed were significantly higher than expected based on clinically confirmed cases in Massachusetts as of March 25. The reason for the discrepancy is not yet clear, and until further experiments are complete, these data do not necessarily indicate that clinical estimates are incorrect. Our approach is scalable and may be useful in modeling the SARS-CoV-2 pandemic and future outbreaks.


Related Papers

No related papers found

Powered by citation graph analysis